 Portal Hypertension IV: Proceedings of the 4th Baveno International Consensus Workshop
ISBN: 978-1-4051-3940-3
Hardcover
424 pages
February 2006, Wiley-Blackwell
US $129.95
 Add to Cart
This price is valid for United States. Change location to view local pricing and availability. Other Available Formats: Adobe E-Book
|
An online version of this product is available through our subscription-based content service. Visit Wiley InterScience now |
LECTURE.
What Have We Accomplished (and What Lies Ahead).
SESSION 1.
Definition of KeyEvents -
Last Attempt?.
BAVENO IV CONSENSUS STATEMENTS.
LECTURE.
Abnormalities of Haemostasis Tests in Chronic Liver Disease: Clinically Relevant?.
SESSION 2.
Predictive Models in Portal Hypertension.
BAVENO IV CONSENSUS STATEMENTS.
SESSION 3.
Prevention of the Formation of Varices (Pre-PrimaryProphy laxis).
BAVENO IV CONSENSUS STATEMENTS.
LECTURE.
PulmonaryVascular Complications of Liver Disease: Implications for Diagnosis and Treatment of Portal Hypertension.
SESSION 4.
PrimaryProphy laxis for Variceal Bleeding.
BAVENO IV CONSENSUS STATEMENTS.
LECTURE.
Hepatorenal Syndrome: Current Concepts.
SESSION 5.
Treatment of the Acute Bleeding Episode.
BAVENO IV CONSENSUS STATEMENTS.
LECTURE.
Spontaneous Bacterial Peritonitis/Infections in Cirrhosis.
SESSION 6.
Prevention of Rebleeding.
BAVENO IV CONSENSUS STATEMENTS.
SESSION 7.
Noncirrhotic Portal Hypertension.
BAVENO IV CONSENSUS STATEMENTS.
LECTURE.
Qualityof Randomised Clinical Trials in Portal Hypertension and Other Fields of Hepatology.
LECTURE.
Value and Limits of Evidence-Based Medicine (EBM).
SESSION 8.
Providing Scientific Evidence: RCTs and Beyond.
.
BAVENO IV CONSENSUS STATEMENTS.
Index
What Have We Accomplished (and What Lies Ahead).
SESSION 1.
Definition of KeyEvents -
Last Attempt?.
BAVENO IV CONSENSUS STATEMENTS.
LECTURE.
Abnormalities of Haemostasis Tests in Chronic Liver Disease: Clinically Relevant?.
SESSION 2.
Predictive Models in Portal Hypertension.
BAVENO IV CONSENSUS STATEMENTS.
SESSION 3.
Prevention of the Formation of Varices (Pre-PrimaryProphy laxis).
BAVENO IV CONSENSUS STATEMENTS.
LECTURE.
PulmonaryVascular Complications of Liver Disease: Implications for Diagnosis and Treatment of Portal Hypertension.
SESSION 4.
PrimaryProphy laxis for Variceal Bleeding.
BAVENO IV CONSENSUS STATEMENTS.
LECTURE.
Hepatorenal Syndrome: Current Concepts.
SESSION 5.
Treatment of the Acute Bleeding Episode.
BAVENO IV CONSENSUS STATEMENTS.
LECTURE.
Spontaneous Bacterial Peritonitis/Infections in Cirrhosis.
SESSION 6.
Prevention of Rebleeding.
BAVENO IV CONSENSUS STATEMENTS.
SESSION 7.
Noncirrhotic Portal Hypertension.
BAVENO IV CONSENSUS STATEMENTS.
LECTURE.
Qualityof Randomised Clinical Trials in Portal Hypertension and Other Fields of Hepatology.
LECTURE.
Value and Limits of Evidence-Based Medicine (EBM).
SESSION 8.
Providing Scientific Evidence: RCTs and Beyond.
.
BAVENO IV CONSENSUS STATEMENTS.
Index
